返回主页 >>   
                             
x

 BRC1501 - 乳腺癌组织芯片

批号 芯粒 大小 厚度 排列 质检/质控 价格 下载
 BRC1501 150 1.1mm 4um 10X15 H&E, IHC 抗纤维蛋白/细胞角蛋白 查询 PDF文件
订购: sales@fanpu.com                         电话: 0773-3119018

适用于:免疫组化或原位杂交对蛋白或RNA分子在多种乳腺癌组织与正常、炎症等组织表达差异性分析。

描述:150芯,包括70例不同类型乳腺癌,5例正常及炎症等组织,双芯布阵。组织经10%中性福尔马林缓冲液固定24小时,用统一标准的方法加工。组织芯片被固定于美国进口的Superfrost Plus 或APES处理的Superfrost 防脱载玻片上。在4°C保存。从发货日开始所有芯片均有6个月的保质期。每片芯片的完整率大于>90%。

芯粒位置

年龄

性别

病理描述

分级

TNM分期

AR

ER

PR

HER2

A1,B1

40

正常/增生

 

 

++, 5%

++, 5%

++, 2%

-

A2,B2

30

正常/增生

 

 

++, 1%

++, 2%

++, 2%

-

A3,B3

46

正常/增生

 

 

-

-

-

-

A4,B4

16

纤维腺瘤

 

 

-

++~+++, 60%

+++, 50%

-

A5,B5

39

纤维腺瘤

 

 

-

-

-

-

A6,B6

28

导管原位癌

I

TisN0M0

-

-

-

+++

A7,B7

63

浸润性导管癌

II~III

T4N2M0

-

-

-

-

A8,B8

43

浸润性导管癌

II~III

T2N1M0

-

-

-

-

A9,B9

52

浸润性导管癌

II~III

T2N0M0

-

++~+++, 50%

++~+++, 10%

++

A10,B10

38

浸润性导管癌

III

T4N0M0

-

-

-

-

A11,B11

74

浸润性导管癌

II~III

T2N0M0

+, 5%

+++, 60%

+, 5%

-

A12,B12

49

浸润性导管癌

II

T2N0M0

-

-

-

+++

A13,B13

67

浸润性导管癌

II~III

T4N0M0

-

+, 30%

-

-

A14,B14

60

浸润性导管癌

II~III

T4N2M0

-

-

-

-

A15,B15

53

浸润性导管癌

III

T3N0M0

-

++, 50%

+, 5%

+~++

C1,D1

47

浸润性导管癌

II

T3N3M0

-

++, 30%

++, 10%

++~+++

C2,D2

49

浸润性导管癌

II

T2N0M0

++, 5%

+++, 60%

+++, 90%

+~++

C3,D3

55

浸润性导管癌

II~III

T4N2M0

+, 5%

++, 80%

+++, 80%

-

C4,D4

34

浸润性导管癌

III

T3N2M0

-

-

-

-

C5,D5

55

浸润性导管癌

II~III

T1N0M0

++, 10%

+++, 80%

+++, 80%

-

C6,D6

51

Paget病

 

TisN0M0

-

-

-

+++

C7,D7

41

导管原位癌

I

TisN0M0

++, 15%

++, 60%

+++, 80%

++

C8,D8

43

浸润性导管癌

II

T2N0M0

+, 2%

-

-

+++

C9,D9

58

浸润性导管癌

III

T2N2M0

+, 2%

-

-

+++

C10,D10

41

浸润性导管癌

II

T2N0M0

+, 5%

+++, 80%

+++, 80%

+~++

C11,D11

44

浸润性导管癌

II~III

T2N0M0

-

++, 60%

++, 10%

+

C12,D12

50

浸润性导管癌

I~II

T2N0M0

-

-

-

+++

C13,D13

 62

浸润性导管癌

II~III

T4N3M0

+, 5%

++, 50%

+~++, 15%

++

C14,D14

54

浸润性小叶癌

III

T2N0M0

-

-

-

-

C15,D15

43

浸润性导管癌

I~II

T2N2M0

-

-

-

+++

E1,F1

48

浸润性导管癌

II~III

T2N2M0

-

-

+++, 50%

-

E2,F2

40

浸润性导管癌

III

T2N0M0

-

-

-

++

E3,F3

50

浸润性导管癌

II

T2N0M0

-

-

-

-

E4,F4

35

浸润性导管癌

II

T2N0M0

++, 2%

+, 5%

++, 50%

-

E5,F5

92

浸润性导管癌

II~III

T2N0M0

-

-

-

+~++

E6,F6

41

浸润性导管癌

II~III

T2N0M0

-

+, 20%

-

++~+++

E7,F7

 58

浸润性导管癌

II~III

T2N0M0

-

-

++, 15%

-

E8,F8

28

浸润性导管癌

I~II

T2N0M0

-

++, 50%

-

-

E9,F9

42

浸润性导管癌

III

T2N0M0

-

-

-

++~+++

E10,F10

50

浸润性导管癌

II~III

T4N3MX

++, 10%

-

-

++

E11,F11

68

浸润性小叶癌

II~III

T3N1M0

-

++, 20%

-

-

E12,F12

64

浸润性导管癌

II~III

T2N0M0

++, 15%

+, 10%

-

+++

E13,F13

62

浸润性导管癌

II~III

T2N0M0

++, 20%

+, 10%

-

+++

E14,F14

50

浸润性导管癌

II

T1N0M0

-

-

-

+++

E15,F15

50

浸润性导管癌

II~III

T4N3M1

-

-

-

-

G1,H1

65

浸润性导管癌

II~III

T2N0M0

-

-

-

-

G2,H2

47

浸润性导管癌

II~III

T3N2M0

++, 20%

++~+++, 30%

++, 5%

+

G3,H3

53

浸润性导管癌

II~III

T2N1M0

+, 10%

-

-

+++

G4,H4

51

浸润性导管癌

II~III

T4N2M1

++, 50%

+++, 100%

-

-

G5,H5

51

浸润性导管癌

I~II

T2N2M0

-

-

-

+++

G6,H6

33

浸润性导管癌

III

T2N0M0

++, 5%

-

-

+++

G7,H7

42

浸润性导管癌

II

T2N0M0

+, 10%

++, 50%

++~+++, 15%

+~++

G8,H8

48

浸润性导管癌

II~III

T2N0M0

-

++, 50%

+++, 20%

+

G9,H9

61

浸润性导管癌

II~III

T2N0M0

-

-

-

+++

G10,H10

 49

浸润性导管癌

II~III

T2N0M0

+~++, 10%

-

-

+++

G11,H11

37

浸润性导管癌

II~III

T2N0M0

-

-

-

-

G12,H12

44

浸润性导管癌

I

T2N0M0

-

+, 10%

-

+++

G13,H13

31

浸润性导管癌

II~III

T2N2M0

+, 2%

+, 10%

++, 5%

++~+++

G14,H14

36

浸润性导管癌

II

T2N0M0

+, 2%

++, 60%

-

+

G15,H15

57

浸润性导管癌

II~III

T2N0M0

++, 30%

+++, 50%

-

-

I1,J1

52

浸润性导管癌

II

T3N3M0

-

-

-

-

I2,J2

55

浸润性导管癌

II

T3N0M0

-

+, 20%

++~+++, 20%

+

I3,J3

37

浸润性导管癌

II~III

T3N1M1

+, 10%

+, 20%

+, 20%

+

I4,J4

54

浸润性导管癌

II

T2N0M0

-

++, 10%

+, 2%

-

I5,J5

43

浸润性导管癌

II~III

T3N1M0

++, 20%

-

-

+~++

I6,J6

54

浸润性小叶癌

III

T2N0M0

-

-

-

+++

I7,J7

58

浸润性导管癌

II~III

T3N1M0

-

-

-

-

I8,J8

40

浸润性小叶癌

III

T2N0M0

-

++, 50%

++, 15%

-

I9,J9

 66

浸润性导管癌

II~III

T3N0M0

-

-

-

+++

I10,J10

29

浸润性导管癌

II~III

T3N1M0

-

-

-

-

I11,J11

46

浸润性导管癌

II~III

T2N1M0

+, 5%

+, 10%

-

+++

I12,J12

40

浸润性导管癌

II~III

T3N0M0

++, 5%

+, 15%

+, 5%

-

I13,J13

46

浸润性导管癌

II~III

T2N0M0

++~+++, 50%

++, 30%

+++, 80%

+++

I14,J14

35

浸润性导管癌

I~II

T4N2M1

++, 5%

++~+++, 60%

+, 5%

+

I15,J15

35

浸润性导管癌

II~III

T2N0M0

-

-

-

+

 
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
所有产品 | 联系我们 | 版权声明
版权所有 © 桂林泛谱生物技术有限公司 桂林市高新区留学人员创业园B座202室 541004